Spoken Alpha
SER
Serina Therapeutics, Inc.
Overview
Serina Therapeutics, Inc is a Healthcare company operating in Biotechnology with a $62.0M market cap.
SER missed consensus EPS by 0.6% in Q2 FY2026, reported Aug 12, 2026.
Behavioral analysis
Management language signature
Disclosures
Investor Relations
Extracted from Unknown source, 2026-08-30.
Transcripts
Recent earnings calls
No earnings calls indexed for SER yet
We index calls for roughly 3,000 US-listed companies. If you'd like us to add SER, reply to your welcome email and we'll prioritize it.
History
Earnings history
- Q2 FY20262026-08-12EPS$-0.55 vs $-0.35-57.1%Rev$0 vs ——EODHD
- Q1 FY20262026-05-13EPS$-0.53 vs $-0.44-20.4%Rev$0 vs ——EODHD
- Q4 FY20252026-03-29EPS$-0.31 vs $-0.50+38.0%Rev$0 vs ——EODHD
- Q3 FY20252025-11-12EPS$-0.51 vs $-0.53+3.8%Rev$0 vs ——EODHD
- Q2 FY20252025-08-10EPS$-0.66 vs $-0.42-57.1%Rev$130.0K vs ——EODHD
- Q1 FY20252025-05-07EPS$-0.49 vs $-0.62+21.0%Rev$0 vs ——EODHD
- Q4 FY20242025-03-19EPS$-0.36 vs $0.42-100.0%Rev$-14.0K vs ——EODHD
- Q3 FY20242024-11-10EPS$0.13 vs ——Rev$14.0K vs ——EODHD
- Q2 FY20242024-08-08EPS$0.51 vs ——Rev$51.0K vs ——EODHD
- Q1 FY20242024-05-13EPS$-3.38 vs ——Rev$5.0K vs ——EODHD
- Q4 FY20232024-03-21EPS$-3.20 vs ——Rev$3.1M vs ——EODHD
- Q3 FY20232023-09-29EPS$-5.01 vs ——Rev$29.0K vs ——EODHD
- Q2 FY20232023-06-29EPS$-2.47 vs ——Rev$7.0K vs ——EODHD
- Q1 FY20232023-03-30EPS$-3.04 vs ——Rev$30.0K vs ——EODHD
- Q4 FY20222023-03-30EPS$-0.07 vs ——Rev$8.0K vs ——EODHD
- Q3 FY20222022-11-09EPS$-0.06 vs ——Rev$9.0K vs ——EODHD
- Q2 FY20222022-08-11EPS$-0.07 vs ——Rev$12.0K vs ——EODHD
- Q1 FY20222022-05-12EPS$-0.07 vs ——Rev$5.0K vs ——EODHD
- Q4 FY20212022-03-28EPS$-0.06 vs ——Rev$2.0K vs ——EODHD
- Q3 FY20212021-11-11EPS$-0.05 vs ——Rev$24.0K vs ——EODHD
| Period | Reported | EPS actual | EPS consensus | EPS surprise | Revenue actual | Revenue consensus | Rev. surprise | Source |
|---|---|---|---|---|---|---|---|---|
| Q2 FY2026 | 2026-08-12 | $-0.55 | $-0.35 | -57.1% | $0 | — | — | EODHD |
| Q1 FY2026 | 2026-05-13 | $-0.53 | $-0.44 | -20.4% | $0 | — | — | EODHD |
| Q4 FY2025 | 2026-03-29 | $-0.31 | $-0.50 | +38.0% | $0 | — | — | EODHD |
| Q3 FY2025 | 2025-11-12 | $-0.51 | $-0.53 | +3.8% | $0 | — | — | EODHD |
| Q2 FY2025 | 2025-08-10 | $-0.66 | $-0.42 | -57.1% | $130.0K | — | — | EODHD |
| Q1 FY2025 | 2025-05-07 | $-0.49 | $-0.62 | +21.0% | $0 | — | — | EODHD |
| Q4 FY2024 | 2025-03-19 | $-0.36 | $0.42 | -100.0% | $-14.0K | — | — | EODHD |
| Q3 FY2024 | 2024-11-10 | $0.13 | — | — | $14.0K | — | — | EODHD |
| Q2 FY2024 | 2024-08-08 | $0.51 | — | — | $51.0K | — | — | EODHD |
| Q1 FY2024 | 2024-05-13 | $-3.38 | — | — | $5.0K | — | — | EODHD |
| Q4 FY2023 | 2024-03-21 | $-3.20 | — | — | $3.1M | — | — | EODHD |
| Q3 FY2023 | 2023-09-29 | $-5.01 | — | — | $29.0K | — | — | EODHD |
| Q2 FY2023 | 2023-06-29 | $-2.47 | — | — | $7.0K | — | — | EODHD |
| Q1 FY2023 | 2023-03-30 | $-3.04 | — | — | $30.0K | — | — | EODHD |
| Q4 FY2022 | 2023-03-30 | $-0.07 | — | — | $8.0K | — | — | EODHD |
| Q3 FY2022 | 2022-11-09 | $-0.06 | — | — | $9.0K | — | — | EODHD |
| Q2 FY2022 | 2022-08-11 | $-0.07 | — | — | $12.0K | — | — | EODHD |
| Q1 FY2022 | 2022-05-12 | $-0.07 | — | — | $5.0K | — | — | EODHD |
| Q4 FY2021 | 2022-03-28 | $-0.06 | — | — | $2.0K | — | — | EODHD |
| Q3 FY2021 | 2021-11-11 | $-0.05 | — | — | $24.0K | — | — | EODHD |
Source: EODHD. SER reported actuals as published; sparse fields render as —.
Top executives
Executives who appear on this company's earnings calls in our corpus, with role and tenure sourced from SEC filings. Click any name for the full role timeline and call appearance history. Per-executive behavioral deviation metrics are available to research subscribers.
- Steven A LedgerCEO2 yrno recorded callsCurrent
- Gregory S CurhanCFO2 yr 1 mono recorded callsCurrent
- Randall MoreadithChief Scientific Officer2 yr 6 mono recorded callsCurrent
- Srini TenjarlaSVP, CMC & Formulation2 yr 2 mono recorded callsCurrent
- Michael J WestCEO4 yr 4 mono recorded callsFormer
- Andrea Eun Jae ParkCFO1 yr 1 mono recorded callsFormer
Peers
Other companies in Healthcare
Sector peers tracked by Spoken Alpha. Each links to the same machine-readable IR surface — earnings calls, executives, and accountability scores.
API
For developers and AI agents
The same data on this page is available as a machine-readable feed via the Spoken Alpha API. One call returns the IR URL, recent transcripts, and accountability scores for SER.
$ curl https://api.spokenalpha.com/v1/companies/SERFAQ
Frequently asked about SER
Where can I find Serina Therapeutics, Inc.'s (SER) earnings call transcripts?
Spoken Alpha indexes SER's earnings call transcripts at https://spokenalpha.com/companies/SER. Each call links to attributed speakers and parsed analyst Q&A. Serina Therapeutics, Inc.'s own investor relations page is at https://investors.serinatx.com/overview/default.aspx.
What sector is SER in?
Serina Therapeutics, Inc. (SER) operates in the Healthcare sector (Biotechnology industry).